MorphoSys Provides Update on MOR102 Program in Psoriasis
April 28, 2005 01:37 ET
|
MorphoSys AG
MARTINSRIED, Germany, April 28, 2005 (PRIMEZONE) -- MorphoSys AG (Frankfurt:MOR) (MOR; Prime Standard Segment, TecDAX) today provided an update on its MOR102 antibody program for chronic inflammatory...
Xenova Grants Licence to PharmaEngine
April 13, 2005 02:12 ET
|
Xenova Group PLC
SLOUGH, U.K., April 13, 2005 (PRIMEZONE) -- Xenova Group plc (Nasdaq:XNVA) (LSE:XEN) today announced that it has entered into a licensing agreement for its lead product candidate, TransMID(TM), with...
Medicover to Acquire Another Laboratory Company and Proposal for a Rights Issue
April 08, 2005 02:06 ET
|
Medicover
STOCKHOLM, Sweden, April 8, 2005 (PRIMEZONE) -- The Board of Directors of the healthcare company, Medicover Holding S.A. (publ), in their meeting on 7th April 2005, authorized management to finalize...
Crucell N.V.: Galapagos is Considering a Stock Exchange Listing
March 09, 2005 03:36 ET
|
Crucell N.V.
LEIDEN, The Netherlands, March 9, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext: CRXL) (Nasdaq:CRXL) announced today that Galapagos Genomics N.V. is considering a Euronext...
Photo Release -- Rite Aid Drugstore Chain To Carry Swiss Medica's O24 Pain Relief Product
January 18, 2005 08:00 ET
|
Swiss Medica
TORONTO, Jan. 18, 2005 (PRIMEZONE) -- Swiss Medica Inc. (OTCBB:SWME) is pleased to announce the Rite Aid Corporation, the third largest U.S. drugstore chain by store count, will begin carrying the...
Hubei Pharmaceutical Group Reports Second Quarter Operational Profit of $681,666
September 23, 2004 09:00 ET
|
Amersin Life Sciences Corp.
NEW YORK, Sept. 23, 2004 (PRIMEZONE) --
---------------------------------------------------------------------
Operational Results Second Quarter Six Months
at a Glance ...